Partner Courtenay Brinckerhoff is quoted in a Law360 article, “Fed. Circ. Clouds Landscape For Medical Treatment Patents,” about a recent appeals court decision invalidating claims of five Mallinckrodt patents on Inomax, a drug used to treat babies with breathing disorders.
Brinckerhoff said the ruling appears to foreclose patents on such methods of non-treatment, though it’s not clear what could make such claims patentable. “I think most of the Federal Circuit judges believe method-of-treatment claims where you’re actually treating someone are eligible,” she said. “My concern is the slippery slope of that line.”
People
Related News
14 February 2025
In the News
Brian Wheeler Joins Podcast to Discuss Legal Journey
Foley & Lardner LLP partner Brian Wheeler joined the Hsu Untied podcast to discuss his legal career.
14 February 2025
In the News
Pavan Agarwal Featured in Leadership Q&A – 'Reflecting our firm’s core values drives me to do my best'
Foley & Lardner LLP partner Pavan Agarwal is featured by Law.com for his career journey, legal practice, and leadership in the article, “How I Made Practice Group Chair: ‘Keep Listening and Keep Learning,’ Says Pavan Agarwal of Foley & Lardner.”
14 February 2025
In the News
Judith Waltz on Trump Administration Deregulation Order, Impact on CMS
Foley & Lardner LLP partner Judith Waltz commented on the Trump administration's executive order requiring federal agencies cut ten regulations for each newly created one in the Modern Healthcare article, "CMS may evade Trump's sweeping deregulation order."